130 related articles for article (PubMed ID: 6724230)
21. Study of the in vivo priming effect of interferon in mice.
Rosztóczy I
J Gen Virol; 1986 Dec; 67 ( Pt 12)():2731-7. PubMed ID: 3794665
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of human leukocyte interferon.
Cantell K; Pyhälä L
J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
[TBL] [Abstract][Full Text] [Related]
24. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph.
Bocci V; Pessina GP; Paulesu L; Nicoletti C
J Biol Response Mod; 1988 Aug; 7(4):390-400. PubMed ID: 3171601
[TBL] [Abstract][Full Text] [Related]
25. The lymphatic route. V. Distribution of human natural interferon-beta in rabbit plasma and lymph.
Bocci V; Pessina GP; Paulesu L; Muscettola M; Valeri A
J Interferon Res; 1988 Oct; 8(5):633-40. PubMed ID: 3235848
[TBL] [Abstract][Full Text] [Related]
26. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of subcutaneous injection and intravenous infusion of recombinant human interleukin-12 and recombinant human interleukin-12 combined with hepatitis B surface antigen in cynomolgus monkeys.
Li R; Deng F; Fu Y; Zhang Y; Wan H; Zhou D; Gu J; Xu J
Pharmacology; 2010; 85(6):319-27. PubMed ID: 20516733
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacokinetics of cefamandole in rabbits].
Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmoset.
Greischel A; Tanswell P; Busch U; Schumacher K
Arzneimittelforschung; 1988 Oct; 38(10):1539-43. PubMed ID: 3196399
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone.
Porchet HC; Le Cotonnec JY; Canali S; Zanolo G
Drug Metab Dispos; 1993; 21(1):144-50. PubMed ID: 8095209
[TBL] [Abstract][Full Text] [Related]
32. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
Buckwold VE; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):62-70. PubMed ID: 16867173
[TBL] [Abstract][Full Text] [Related]
33. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
Sugiyama M; Morisaki N; Konishi K; Go K; Sugita M; Nakai Y
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of human recombinant interferon-alpha I after i.v. infusion and im injection in African green monkeys.
Wills RJ; Soike KF
J Interferon Res; 1988 Aug; 8(4):427-32. PubMed ID: 3171243
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Buchwalder PA; Buclin T; Trinchard I; Munafo A; Biollaz J
J Interferon Cytokine Res; 2000 Oct; 20(10):857-66. PubMed ID: 11054273
[TBL] [Abstract][Full Text] [Related]
36. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
Edy VG; Billiau A; De Somer P
J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of the Sri Lankan hump-nosed pit viper (Hypnale hypnale) venom following intravenous and intramuscular injections of the venom into rabbits.
Tan CH; Sim SM; Gnanathasan CA; Fung SY; Tan NH
Toxicon; 2014 Mar; 79():37-44. PubMed ID: 24412778
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of recombinant alpha A interferon following I.V. infusion and bolus, I.M., and P.O. administrations to African green monkeys.
Wills RJ; Spiegel HE; Soike KF
J Interferon Res; 1984; 4(3):399-409. PubMed ID: 6491397
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha 2 interferon in patients with malignancies.
Shah I; Band J; Samson M; Young J; Robinson R; Bailey B; Lerner AM; Prasad AS
Am J Hematol; 1984; 17(4):363-71. PubMed ID: 6594039
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
Abd El-Aty AM; Goudah A; Abo El Sooud K
Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
